Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/08/1521 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FWBIFirst Wave BioPharma Inc
2024/08/1521 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:URGNUroGen Pharma Ltd
2024/08/1521 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:GNTLFGenetic Technologies Ltd (PK)
2024/08/1521 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EXLSExlService Holdings Inc
2024/08/1521 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NVMINova Ltd
2024/08/1521 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:PRTGPortage Biotech Inc
2024/08/1521 : 00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:CBDBA Chubb Limited
2024/08/1521 : 00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:BOCNUBlue Ocean Acquisition Corporation
2024/08/1521 : 00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FTCIFTC Solar Inc
2024/08/1521 : 00Business WireJBL Announces R.J. Davis (North Carolina), Riley McCusker (Florida), Danny Stutsman (Oklahoma) and More as Part of the 2024 JBL Campus Program, Empowering Students to Express Their Unique Voices at the Intersection of Music, Sports, and Lifestyle
2024/08/1521 : 00GlobeNewswire Inc.Greenridge Exploration Provides Updated Technical Review of its Nut Lake Uranium Project in the Thelon Basin, NunavutHW3
2024/08/1521 : 00Business WireDermBiont Announces Treatment of Locally Advanced Basal Cell Carcinoma and Prevention of Basal Cell Carcinoma in Gorlin Syndrome Patients as New Lead Indications for SM-020 Following Positive Initial Phase 2a Data
2024/08/1521 : 00GlobeNewswire Inc.ABM Awarded NASPO ValuePoint® Contract for EV Charging Infrastructure SolutionsNYSE:ABMABM Industries Inc
2024/08/1521 : 00GlobeNewswire Inc.Soleno Therapeutics Announces Updates to its Board of DirectorsNASDAQ:SLNOSoleno Therapeutics Inc
2024/08/1521 : 00Business WireNeptune Medical Announces $97M Series D Financing and Spinout of Jupiter Endovascular
2024/08/1521 : 00Business WireNexstar Media Group to Report 2024 Third Quarter Financial Results, Host Conference Call and Webcast on November 7NASDAQ:NXSTNexstar Media Group Inc
2024/08/1521 : 00Business Wire505 Southwestern’s Fire Roasted Salsas Have Landed at King Soopers
2024/08/1521 : 00Business WireSomfy North America Launches Web App to Enable Dealers to Provide Enhanced After-Sales Support
2024/08/1521 : 00GlobeNewswire Inc.Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit
2024/08/1521 : 00Business WireNextGen Growth Partners Closes Oversubscribed Fund III at $165M Hard Cap, Championing Entrepreneurial Approach
2024/08/1521 : 00Business WireIt’s Time Seat Manufacturers Get Heads in the Right Place, J.D. Power Finds
2024/08/1521 : 00GlobeNewswire Inc.Heliene and NorSun Sign Multi-Year Partnership Contract for Supply of US Made Wafers
2024/08/1521 : 00Business WireClearBridge Midstream Funds Announce Merger Timing UpdateNYSE:CEMClearBridge MLP and Midstream Fund Inc
2024/08/1521 : 00GlobeNewswire Inc.Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platformGTG.AX
2024/08/1521 : 00Business WireSplunk Named a Leader in the Gartner® Magic Quadrant for Observability Platforms for the Second Consecutive Year
2024/08/1521 : 00GlobeNewswire Inc.FORTNA Named in Gartner® Hype Cycle™ for Supply Chain Execution Technologies, 2024
2024/08/1521 : 00Business WireGo Addressable Releases New Research Demonstrating the Importance of Addressable TV Advertising Among Adults 18-34 Amid Signal LossNASDAQ:CMCSAComcast Corporation
2024/08/1521 : 00Business WireVista Equity Partners Names Winners of 7th Annual Global Hackathon
2024/08/1521 : 00Business WireExaGrid Named to Prestigious MES Midmarket 100
2024/08/1521 : 00GlobeNewswire Inc.Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular CarcinomaNASDAQ:TPSTTempest Therpeutics Inc

最近閲覧した銘柄

Delayed Upgrade Clock